Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Emberton

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Contemporary Clinical Trials|July 18, 2015
The FORECAST study - Focal recurrent assessment and salvage treatment for radiorecurrent prostate cancerA Kanthabalan, T Shah, M Arya, et al.
Prostate Cancer and Prostatic Diseases|July 20, 2016
PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failureT T Shah, M Peters, A Kanthabalan, et al.
Actas Urologicas Espanolas|March 12, 2014
Focal therapy for prostate cancer. Alternative treatmentF Gómez-Veiga, S Martínez-Breijo, E Solsona-Narbón, et al.
The Journal of Urology|December 3, 2015
The Prevalence of Clinically Significant Prostate Cancer According to Commonly Used Histological Thresholds in Men Undergoing Template Prostate Mapping BiopsiesM Valerio, C Anele, S R J Bott, et al.
Research Involvement and Engagement|November 18, 2021
ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagementS Green, S Tuck, J Long, et al.
Brachytherapy|March 8, 2016
Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancerM Peters, J R N van der Voort van Zyp, M A Moerland, et al.
Journal of Endourology|May 19, 2010
Focal therapy in prostate cancer-report from a consensus panelJ de la Rosette, H Ahmed, J Barentsz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parametersM Linch, G Goh, C Hiley, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Contemporary Clinical Trials|July 18, 2015
The FORECAST study - Focal recurrent assessment and salvage treatment for radiorecurrent prostate cancerA Kanthabalan, T Shah, M Arya, et al.
Prostate Cancer and Prostatic Diseases|July 20, 2016
PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failureT T Shah, M Peters, A Kanthabalan, et al.
Actas Urologicas Espanolas|March 12, 2014
Focal therapy for prostate cancer. Alternative treatmentF Gómez-Veiga, S Martínez-Breijo, E Solsona-Narbón, et al.
The Journal of Urology|December 3, 2015
The Prevalence of Clinically Significant Prostate Cancer According to Commonly Used Histological Thresholds in Men Undergoing Template Prostate Mapping BiopsiesM Valerio, C Anele, S R J Bott, et al.
Research Involvement and Engagement|November 18, 2021
ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagementS Green, S Tuck, J Long, et al.
Brachytherapy|March 8, 2016
Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancerM Peters, J R N van der Voort van Zyp, M A Moerland, et al.
Journal of Endourology|May 19, 2010
Focal therapy in prostate cancer-report from a consensus panelJ de la Rosette, H Ahmed, J Barentsz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parametersM Linch, G Goh, C Hiley, et al.
Pageof 11